Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Published in : 06 Aug 2026

Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

Read full article from source